Skip to main content
Clinical Trials/CTRI/2023/01/048791
CTRI/2023/01/048791
Not yet recruiting
Phase 1

A comparative evaluation for anxiolytic activity of Medhya Rasayana Ghrita administered by Nasya (Nasal route) versus Shamana Snehpana (oral administration) on occupational stress.

Datta Meghe Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: F432- Adjustment disorders
Sponsor
Datta Meghe Institute of Medical Sciences
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects who are willing to give written informed consent.
  • 2\. Serum cortisol level \> 15 mcg/dl, OSI score. ( 128\-230\.DownloadsOSI SCALE.pdf)
  • 3\.Subjects of either gender between 25 to 40 years
  • 4\.Subjects who are fit (yogya) for Nasya Karma \& Shamana Snehapana
  • 5 Subjects of Madhyam Koshta,Madhyam Agnibala (samagni) will be included.

Exclusion Criteria

  • 1\.Participants having ages less than 25 and more than 40 years of age of either sex.2\. Person suffering from other psychiatric illnesses and using other anti\-psychiatric medication 3\..Patient suffering from any systemic chronic illness e.g., Asthma, COPD, Anemia, hepatic dysfunction, renal dysfunction, and Resistant hypertension, etc.4\.Participants with a history of alcoholism and drug abuse.5\. Pregnant, breastfeeding, or planning to become pregnant during the study.6\. Peri\-menopausal women. Patients having Nasal obstructive Pathology like congestion, Deviated Nasal septum, Nasal polyps etc . 7\.Patients contraindicated for Nasya according to classics.. 8\.Patients contraindicated for Shamana Snehapana

Outcomes

Primary Outcomes

Not specified

Similar Trials